Quarterly Report • Apr 21, 2015
Quarterly Report
Open in ViewerOpens in native device viewer
| Total return | |||||
|---|---|---|---|---|---|
| NAV (%)* | Investor B (%) | SIXRX (%) | |||
| Q1 2015 | 13.3 | 20.7 | 15.8 | ||
| 1 year | 33.4 | 51.5 | 27.7 | ||
| 5 years | 17.1 | 24.2 | 15.0 | ||
| 10 years | 14.0 | 17.4 | 12.6 | ||
| 20 years | 14.2 | 15.0 | 13.1 | ||
| *Incl. dividend added back | |||||
| 3/31 2015 | |||||
| NAV, SEK per share | 388 | ||||
| Share price (B-share), SEK | 343.70 |
This page has intentionally been left blank in your copy
| Number of | Ownership | Share of total | Value, | Value, | Contribution to | Value, | |
|---|---|---|---|---|---|---|---|
| shares | capital/votes1) (%) | assets | SEK/share | SEK m.2) | net asset value | SEK m.2) | |
| 3/31 2015 | 3/31 2015 | 3/31 2015 (%) | 3/31 2015 | 3/31 2015 | 2015 | 12/31 2014 | |
| Core Investments | |||||||
| Listed3) | |||||||
| Atlas Copco | 206 895 611 | 16.8/22.3 | 18 | 76 | 57 470 | 12 498 | 44 972 |
| SEB | 456 198 927 | 20.8/20.8 | 14 | 60 | 46 038 | 2 798 | 45 407 |
| ABB | 205 365 142 | 8.9/8.9 | 12 | 49 | 37 599 | 3 446 | 33 192 |
| AstraZeneca | 51 587 810 | 4.1/4.1 | 9 | 40 | 30 643 | 3 179 | 28 270 |
| Ericsson | 175 047 348 | 5.3/21.5 | 6 | 24 | 18 159 | 2 352 | 15 807 |
| Wärtsilä | 33 366 544 | 16.9/16.9 | 4 | 17 | 12 764 | 1 348 | 11 776 |
| Electrolux | 47 866 133 | 15.5/30.0 | 4 | 16 | 11 833 | 1 192 | 10 952 |
| Sobi | 107 594 165 | 39.7/39.8 | 3 | 13 | 9 796 | 1 264 | 8 532 |
| Nasdaq | 19 394 142 | 11.5/11.5 | 3 | 11 | 8 518 | 1 276 | 7 266 |
| Saab | 32 778 098 | 30.0/39.5 | 2 | 10 | 7 552 | 928 | 6 624 |
| Husqvarna | 97 052 157 | 16.8/31.9 | 2 | 8 | 6 056 | 458 | 5 598 |
| 77 | 324 | 246 428 | 30 739 | 218 396 | |||
| Subsidiaries | |||||||
| Mölnlycke Health Care | 99/99 | 8 | 30 | 22 927 | -25 | 22 952 | |
| Aleris | 100/100 | 1 | 5 | 3 802 | 40 | 3 762 | |
| Permobil | 94/90 | 1 | 5 | 3 695 | -40 | 3 737 | |
| Grand Group/Vectura | 100/100 | 0 | 2 | 1 448 | -23 | 1 471 | |
| 10 | 42 | 31 872 | -48 | 31 922 | |||
| 87 | 365 | 278 300 | 30 6574) | 250 318 | |||
| Financial Investments | |||||||
| EQT | 4 | 18 | 13 991 | 1 027 | 13 522 | ||
| Investor Growth Capital | 5 | 20 | 15 119 | 3 051 | 12 081 | ||
| Partner-owned investments | |||||||
| 3 Scandinavia | 40/40 | 2 | 8 | 5 943 | 72 | 6 123 | |
| Other Investments5) | 1 | 5 | 4 021 | -157 | 3 780 | ||
| 12 | 51 | 39 074 | 3 9814) | 35 506 | |||
| Other Assets and Liabilities | 1 | 3 | 2 5026) | 1894) | -29 | ||
| Total Assets | 100 | 420 | 319 876 | 285 795 | |||
| Net debt | -8 | -32 | -24 086 | -24 832 | |||
| Net Asset Value | 92 | 388 | 295 790 | 34 827 | 260 963 | ||
1) Calculated in accordance with the disclosure regulations of Sweden's Financial Instruments Trading Act (LHF). ABB, AstraZeneca, Nasdaq and Wärtsilä in accordance with Swiss, British, U.S. and Finnish regulations.
2) Includes market value of derivatives related to investments if applicable. The subsidiaries within Core Investments and the partner-owned investments within Financial Investments are reported according to the acquisition method and equity method respectively.
3) Valued according to the class of share held by Investor, with the exception of Saab and Electrolux, for which the most actively traded class of share is used.
4) Including management costs, of which Core Investments SEK 34 m., Financial Investments SEK 12 m. and Groupwide SEK 49 m.
5) Includes a number of investments and Investor's trading activities.
6) Dividends from listed core investments of SEK 2,478 m. pending over the end of the quarter have been accounted for as receivables in Other Assets and Liabilities.
During the first quarter 2015, the net asset value increased from SEK 261.0 bn. to SEK 295.8 bn. The change in net asset value, with dividend added back, was 13 percent (6) 1) .The corresponding total return of the Stockholm Stock Exchange (SIXRX) was 16 percent.
1) For balance sheet items, figures in parentheses refer to year-end 2014 figures. For income statement items, the figures in parentheses refer to the same period last year.
Net debt totaled SEK 24,086 m. on March 31, 2015 (24,832), corresponding to leverage of 7.5 percent (8.7). Adjusted for dividend paid and dividends still expected to be received, leverage would have been 7.8 percent.
| SEK m. | Q1 2015 | 2014 |
|---|---|---|
| Opening net debt | -24 832 | -23 104 |
| Core Investments | ||
| Dividends | 1 1901) | 6 227 |
| Other capital distributions | - | 1 198 |
| Investments, net of proceeds | -961 | -9 245 |
| Financial Investments | ||
| Capital distribution, including dividends | 302 | 1 778 |
| Proceeds, net of investments | 187 | 6 932 |
| Investor Groupwide | ||
| Other | 28 | -2 529 |
| Dividends paid | - | -6 089 |
| Closing net debt | -24 086 | -24 832 |
1) Dividends from listed core investments of SEK 2,478 m. pending over the end of the quarter have been accounted for as receivables in Other Assets and Liabilities.
| Q1 2015 | Core Investments | |||||
|---|---|---|---|---|---|---|
| SEK m. | Listed | Subsidiaries | Total | Financial Investments |
Investor Groupwide |
Total |
| Dividends | 3 668 | 3 668 | 3 | 3 671 | ||
| Other operating income | 16 | 16 | ||||
| Changes in value | 27 071 | 27 071 | 3 126 | 30 197 | ||
| Net sales | 5 713 | 5 713 | 15 | 5 728 | ||
| Management cost | -34 | -12 | -49 | -95 | ||
| Other items | -5 124 | -5 124 | -124 | -256 | -5 504 | |
| Profit/loss for the period | 30 739 | 589 | 31 294 | 3 024 | -305 | 34 013 |
| Non-controlling interest | 0 | 0 | ||||
| Other effects on equity | -637 | -637 | 957 | 494 | 814 | |
| Contribution to net asset value | 30 739 | -48 | 30 657 | 3 981 | 189 | 34 827 |
| Net asset value, March 31, 2015 | ||||||
| Carrying amount | 246 428 | 31 872 | 278 300 | 39 074 | 2 502 | 319 876 |
| Investor's net debt | -24 086 | -24 086 | ||||
| Total net asset value | 246 428 | 31 872 | 278 300 | 39 074 | -21 584 | 295 790 |
| Q1 2014 | Core Investments | ||||||
|---|---|---|---|---|---|---|---|
| SEK m. | Listed | Subsidiaries | Total | Financial Investments |
Investor Groupwide |
Total | |
| Dividends | 2 915 | 2 915 | 470 | 3 385 | |||
| Other operating income | 52 | 52 | |||||
| Changes in value | 7 268 | -3 | 7 265 | 1 628 | 8 893 | ||
| Net sales | 4 883 | 4 883 | 4 883 | ||||
| Management cost | -38 | -13 | -39 | -90 | |||
| Other items | -4 464 | -4 464 | -56 | -440 | -4 960 | ||
| Profit/loss for the period | 10 183 | 416 | 10 561 | 2 081 | -479 | 12 163 | |
| Non-controlling interest | -21 | -21 | -21 | ||||
| Other effects on equity | 45 | 45 | -27 | 7 | 25 | ||
| Contribution to net asset value | 10 183 | 440 | 10 585 | 2 054 | -472 | 12 167 | |
| Net asset value, March 31, 2014 | |||||||
| Carrying amount | 182 684 | 29 974 | 212 658 | 33 276 | 3 573 | 249 507 | |
| Investor's net debt | -21 923 | -21 923 | |||||
| Total net asset value | 182 684 | 29 974 | 212 658 | 33 276 | -18 350 | 227 584 |
Core Investments contributed to the net asset value with SEK 30,657 m. during the first quarter 2015 (10,585).
Read more at www.investorab.com under "Our Investments" >>
| SEK m. | Q1 2015 | Q1 2014 |
|---|---|---|
| Changes in value, listed | 27 071 | 7 268 |
| Dividends, listed | 3 668 | 2 915 |
| Change in reported value, subsidiaries | -48 | 440 |
| Management cost | -34 | -38 |
| Total | 30 657 | 10 585 |
Listed core investments contributed to the net asset value with SEK 30,739 m. during the first quarter 2015 (10,183). The combined total return amounted to 14 percent.
Dividends received totaled SEK 3,668 m. during the first quarter 2015 (2,915), of which SEK 2,478 m. (SEB and Electrolux) were pending and reported in Other Assets and Liabilities. We expect to receive approximately SEK 7.5 bn. in total during 2015.
| Value, SEK m. | Contribution to net asset value, SEK m. |
Total return, Investor1) (%) |
|
|---|---|---|---|
| Listed | |||
| Atlas Copco | 57 470 | 12 498 | 27.8 |
| SEB | 46 038 | 2 798 | 6.2 |
| ABB | 37 599 | 3 446 | 10.4 |
| AstraZeneca | 30 643 | 3 179 | 11.2 |
| Ericsson | 18 159 | 2 352 | 14.9 |
| Wärtsilä | 12 764 | 1 348 | 11.4 |
| Electrolux | 11 833 | 1 192 | 10.9 |
| Sobi | 9 796 | 1 264 | 14.8 |
| Nasdaq | 8 518 | 1 276 | 17.6 |
| Saab | 7 552 | 928 | 14.0 |
| Husqvarna | 6 056 | 458 | 8.2 |
| Total | 246 428 | 30 739 |
1) Calculated as the sum of share price changes and dividends added back, including add-on investments and/or divestments.
5,400,000 shares were purchased in ABB for SEK 961 m.
| A provider of compressors, vacuum and air treatment systems, construction and mining equipment, power tools and assembly systems |
www.atlascopco.com |
|---|---|
| A financial services group with main focus on the Nordic countries, Germany and the Baltics | www.seb.se |
| A provider of power and automation technologies for utility and industry customers | www.abb.com |
| An innovation-driven, integrated biopharmaceutical company | www.astrazeneca.com |
| A provider of communication technologies and services | www.ericsson.com |
| A provider of complete lifecycle power solutions for the marine and energy markets | www.wartsila.com |
| A provider of household appliances and appliances for professional use | www.electrolux.com |
| A specialty healthcare company developing and delivering innovative therapies and services to treat rare diseases |
www.sobi.com |
| A provider of trading, exchange technology, information and public company services across six continents |
www.nasdaq.com |
| A provider of products, services and solutions for military defense and civil security | www.saab.com |
| A provider of outdoor power products, cutting equipment and diamond tools as well as consumer watering products |
www.husqvarna.com |
The subsidiaries contributed to the net asset value with SEK -48 m. during the first quarter 2015 (440). The negative contribution was mainly related to foreign exchange rate effects.
No investments or divestments made by Investor during the quarter.
| 3/31 2015 | 12/31 2014 | ||||
|---|---|---|---|---|---|
| SEK/share | SEK m. | SEK/share | SEK m. | ||
| Mölnlycke Health Care | 30 | 22 927 | 30 | 22 952 | |
| Aleris | 5 | 3 802 | 5 | 3 762 | |
| Permobil | 5 | 3 695 | 5 | 3 737 | |
| Grand Group/Vectura | 2 | 1 448 | 2 | 1 471 | |
| Total | 42 | 31 872 | 42 | 31 922 |
| SEK m. | Q1 2015 | Q1 2014 |
|---|---|---|
| Mölnlycke Health Care | -25 | 369 |
| Aleris | 40 | 17 |
| Permobil | -40 | 15 |
| Grand Group/Vectura | -23 | 39 |
| Total | -48 | 440 |
Read more at www.molnlycke.com >>
A provider of single-use surgical and wound care products for customers, healthcare professionals and patients
| Income statement items, EUR m. | Q1 2015 | Q1 2014 | Rolling 4 quarters |
|
|---|---|---|---|---|
| Sales | 321 | 287 | 1 247 | |
| Sales growth, % | 12 | 4 | ||
| Sales growth, constant currency, % | 4 | 6 | ||
| EBITDA | 89 | 77 | 361 | |
| EBITDA, % | 28 | 27 | 29 | |
| Balance sheet items, EUR m. | 3/31 2015 | 12/31 2014 | ||
| Net debt | 628 | 643 | ||
| Cash flow items, EUR m. | Q1 2015 | Q1 2014 | ||
| EBITDA | 89 | 77 | ||
| Change in working capital | -26 | -22 | ||
| Capital expenditures | -10 | -10 | ||
| Operating cash flow | 53 | 45 | ||
| Acquisitions/divestments | - | - | ||
| Shareholder contribution/distribution | - | - | ||
| Other1) | -38 | -15 | ||
| Increase (-) /decrease (+) in net debt | 15 | 30 | ||
| Key ratios | Rolling 4 quarters |
|||
| Working capital/sales, % | 11 | |||
| Capital expenditures/sales, % | 4 | |||
| 3/31 2015 | 3/31 2014 | |||
| Number of employees | 7 515 | 7 390 |
1) Includes effects of exchange rate changes, interest and tax. During the first quarter 2015, foreign exchange rate–related effects from revaluation of Net debt amounted to EUR -20 m. (-1).
A private provider of healthcare and care services in Scandinavia
| Income statement items, SEK m. | Q1 2015 | Q1 2014 | Rolling 4 quarters |
|
|---|---|---|---|---|
| Sales | 2 066 | 1 841 | 7 752 | |
| Sales growth, % | 12 | 5 | ||
| Organic growth, | ||||
| constant currency, % | 8 | 5 | ||
| EBITDA | 137 | 101 | 391 | |
| EBITDA, % | 7 | 5 | 5 | |
| Balance sheet items, SEK m. | 3/31 2015 | 12/31 2014 | ||
| Net debt | 986 | 969 | ||
| Cash flow items, SEK m. | Q1 2015 | Q1 2014 | ||
| EBITDA | 137 | 101 | ||
| Change in working capital | -89 | -72 | ||
| Capital expenditures | -34 | -53 | ||
| Operating cash flow | 14 | -24 | ||
| Acquisitions/divestments | - | - | ||
| Shareholder contribution/distribution | - | - | ||
| Other1) | -31 | 8 | ||
| Increase (-) /decrease (+) in net debt | -17 | -16 | ||
| Key ratios | Rolling 4 quarters |
|||
| Working capital/sales, % | -2 | |||
| Capital expenditures/sales, % | 2 | |||
| 3/31 2015 | 3/31 2014 | |||
| Number of employees | 6 960 | 6 375 |
1) Includes effects of exchange rate changes, interest and tax. The first quarter 2015 number includes a SEK -80 m. escrow deposit related to the acquisition of Teres Medical Group.
A provider of advanced powered and manual wheelchairs for severly disabled users
| Income statement items, SEK m. | Q1 2015 | Q1 2014 | Rolling 4 quarters |
|
|---|---|---|---|---|
| Sales | 531 | 411 | 2 173 | |
| Sales growth, % | 29 | 8 | ||
| Organic growth, | ||||
| constant currency, % | -3 | 8 | ||
| EBITDA | 62 | 63 | 425 | |
| EBITDA, % | 12 | 15 | 20 | |
| Balance sheet items, SEK m. | 3/31 2015 | 12/31 2014 | ||
| Net debt | 1 592 | 1 451 | ||
| Cash flow items, SEK m. | Q1 2015 | Q1 2014 | ||
| EBITDA | 62 | 63 | ||
| Change in working capital | 1 | 40 | ||
| Capital expenditures | -43 | -35 | ||
| Operating cash flow | 20 | 68 | ||
| Acquisitions/divestments | - | - | ||
| Shareholder contribution/distribution | - | - | ||
| Other1) | -161 | -22 | ||
| Increase (-) /decrease (+) in net debt | -141 | 46 | ||
| Rolling 4 | ||||
| Key ratios | quarters | |||
| Working capital/sales, % | 21 | |||
| Capital expenditures/sales, % | 8 | |||
| 3/31 2015 | 3/31 2014 | |||
| Number of employees | 1 050 | 765 |
1) Includes effects of exchange rate changes, interest and tax. During the first quarter 2015, foreign exchange rate-related effects amounted to SEK -111 m. from revaluation of Net debt (1).
Read more at www.grandhotel.se >>
Grand Hôtel, Scandinavia's leading five-star hotel, and Lydmar Hotel
| Income statement items, SEK m. | Q1 2015 | Q1 2014 | Rolling 4 quarters |
|---|---|---|---|
| Sales | 103 | 92 | 552 |
| Sales growth, % | 12 | 26 | |
| Organic growth, % | 12 | 12 | |
| EBITDA | -11 | -13 | 32 |
| EBITDA, % | -11 | -14 | 6 |
| 3/31 2015 | 3/31 2014 | ||
| Number of employees | 310 | 295 |
Manages Investor's real estate, including Grand Hôtel and Aleris-related properties
| Income statement items, SEK m. | Q1 2015 | Q1 2014 | Rolling 4 quarters |
|---|---|---|---|
| Sales | 28 | 26 | 132 |
| Sales growth, % | 8 | 30 | |
| EBITDA | 15 | 13 | 75 |
| EBITDA, % | 54 | 50 | 57 |
| Balance sheet items, SEK m. | 3/31 2015 | 12/31 2014 |
|---|---|---|
| Net debt, Grand Group/Vectura | 1 294 | 1 278 |
Financial Investments contributed to the net asset value with SEK 3,981 m. during the first quarter 2015 (2,054).
Read more at www.investorab.com under "Our Investments" >>
In total, SEK 1,252 m. was invested and SEK 1,704 m. was distributed to Investor.
| 3/31 2015 | 12/31 2014 | ||||
|---|---|---|---|---|---|
| SEK/Share | SEK m. | SEK/Share | SEK m. | ||
| EQT | 18 | 13 991 | 18 | 13 522 | |
| Investor Growth Capital | 20 | 15 119 | 16 | 12 081 | |
| Partner-owned | |||||
| 3 Scandinavia | 8 | 5 943 | 8 | 6 123 | |
| Other investments | 5 | 4 021 | 5 | 3 780 | |
| Total | 51 | 39 074 | 47 | 35 506 |
| SEK m. | Q1 2015 | Q1 2014 |
|---|---|---|
| EQT | 1 027 | 1 105 |
| Investor Growth Capital | 3 051 | 926 |
| Partner-owned | ||
| Lindorff | - | 74 |
| 3 Scandinavia | 72 | 112 |
| Other investments | -157 | -150 |
| Management cost | -12 | -13 |
| Total | 3 981 | 2 054 |
A private equity group with portfolio companies in Northern and Eastern Europe, Asia and the U.S.
| SEK m. | Q1 2015 | Q1 2014 |
|---|---|---|
| Net asset value, beginning of period | 13 522 | 11 615 |
| Contribution to net asset value (value change) |
1 027 | 1 105 |
| Draw-downs (investments and management fees) |
868 | 367 |
| Proceeds to Investor (divestitures, fee surplus and carry) |
-1 426 | -1 235 |
| Net asset value, end of period | 13 991 | 11 852 |
Read more at www.investorgrowthcapital.com >>
Manages expansion stage venture capital investments in the U.S. and China
| SEK m. | Q1 2015 | Q1 2014 |
|---|---|---|
| Net asset value, beginning of period | 12 081 | 10 793 |
| Contribution to net asset value (value change) |
3 051 | 926 |
| Distribution to Investor | -131) | -3621) |
| Net asset value, end of period | 15 119 | 11 357 |
| Of which net cash | 4 730 | 3 596 |
1) The distribution was pending over the closing of the quarter and was presented as a receivable in Other Assets and Liabilities.
As of March 31, 2015, the U.S. and Asian portfolios represented 53 and 47 percent of the total value respectively and 48 percent was listed holdings, all numbers excluding net cash held by IGC. Of the listed holdings, one holding represented 79 percent. Net cash represented 31 percent of IGC's net asset value.
The five largest investments were (in alphabetical order): ChinaCache (China), Mindjet Corporation (U.S.), NS Focus (China), Retail Solutions (U.S.) and WhiteHat Security (U.S). These holdings represented 53 percent of the total portfolio value, excluding net cash.
Read more at www.tre.se >>
A provider of mobile voice and broadband services in Sweden and Denmark
| Rolling 4 | |||
|---|---|---|---|
| Income statement items | Q1 2015 | Q1 2014 | quarters |
| Sales, SEK m. | 2 663 | 2 324 | 10 726 |
| Sweden, SEK m. | 1 724 | 1 542 | 6 815 |
| Denmark, DKK m. | 746 | 659 | 3 150 |
| Service revenue2), SEK m. | 1 532 | 1 346 | 5 949 |
| Sweden, SEK m. | 1 013 | 862 | 3 881 |
| Denmark, DKK m. | 413 | 407 | 1 669 |
| EBITDA, SEK m. | 696 | 618 | 2 740 |
| Sweden, SEK m. | 512 | 433 | 1 947 |
| Denmark, DKK m. | 146 | 156 | 639 |
| EBITDA, % | 26 | 27 | 26 |
| Sweden | 30 | 28 | 29 |
| Denmark | 20 | 24 | 20 |
| Balance sheet items | 3/31 2015 | 12/31 2014 | |
| Net debt, SEK m. | 1 116 | 1 118 | |
| Q1 2015 | Q1 2014 | ||
| Number of employees | 2 120 | 2 055 | |
| Key figures | Rolling 4 quarters |
||
| Capital expenditures/sales, % | 9 | ||
| Other key figures | 3/31 2015 | 3/31 2014 | |
| Subscribers | 3 047 000 | 2 779 000 | |
| Sweden | 1 920 000 | 1 730 000 | |
| Denmark | 1 127 000 | 1 049 000 | |
| Postpaid/prepaid ratio | 80/20 | 82/18 |
1) As of the fourth quarter 2014, 3 Scandinavia reports all financial information without the previously applied one-month delay. The key figures have been restated to enable comparability.
2) Mobile service revenue excluding interconnect revenue.
| Q1 | FY | Q4 | Q3 | Q2 | Q1 | FY | Q4 | Q3 | Q2 | Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015 | 2014 | 2014 | 2014 | 2014 | 2014 | 2013 | 2013 | 2013 | 2013 | 2013 | |
| Core Investments – Subsidiaries | |||||||||||
| Mölnlycke Health Care (EUR m.) | |||||||||||
| Sales | 321 | 1 213 | 325 | 304 | 297 | 287 | 1 153 | 300 | 284 | 292 | 277 |
| EBITDA | 89 | 349 | 101 | 94 | 77 | 77 | 344 | 97 | 87 | 86 | 74 |
| EBITDA (%) | 28 | 29 | 31 | 31 | 26 | 27 | 30 | 32 | 31 | 29 | 27 |
| Net debt | 628 | 643 | 643 | 730 | 646 | 698 | 728 | 728 | 822 | 1 358 | 1 399 |
| Employees | 7 515 | 7 425 | 7 425 | 7 435 | 7 515 | 7 390 | 7 375 | 7 375 | 7 340 | 7 390 | 7 265 |
| Aleris (SEK m.) | |||||||||||
| Sales | 2 066 | 7 527 | 1 999 | 1 793 | 1 894 | 1 841 | 6 975 | 1 807 | 1 645 | 1 767 | 1 756 |
| EBITDA | 137 | 355 | 60 | 117 | 77 | 101 | 307 | 38 | 79 | 105 | 85 |
| EBITDA (%) | 7 | 5 | 3 | 7 | 4 | 5 | 4 | 2 | 5 | 6 | 5 |
| Net debt | 986 | 969 | 969 | 1 003 | 970 | 1 007 | 991 | 991 | 1 970 | 1 983 | 2 190 |
| Employees | 6 960 | 6 645 | 6 645 | 6 605 | 6 485 | 6 375 | 6 220 | 6 220 | 6 175 | 6 070 | 5 995 |
| Permobil1) (SEK m.) | |||||||||||
| Sales | 531 | 2 053 | 597 | 563 | 482 | 411 | 1 742 | 472 | 450 | 438 | 382 |
| EBITDA | 62 | 426 | 122 | 138 | 103 | 63 | 255 | 77 | 68 | 50 | 60 |
| EBITDA (%) | 12 | 21 | 20 | 25 | 21 | 15 | 15 | 16 | 15 | 11 | 16 |
| Net debt | 1 592 | 1 451 | 1 451 | 1 476 | 1 421 | 1 071 | 1 117 | 1 117 | 1 161 | 1 291 | 1 235 |
| Employees | 1 050 | 1 015 | 1 015 | 995 | 955 | 765 | 775 | 775 | 775 | 750 | 710 |
| Grand Group (SEK m.) | |||||||||||
| Sales | 103 | 541 | 155 | 148 | 146 | 92 | 462 | 145 | 131 | 113 | 73 |
| EBITDA | -11 | 30 | 13 | 16 | 14 | -13 | -5 | 7 | 3 | 0 | -15 |
| EBITDA (%) | -11 | 6 | 8 | 11 | 10 | -14 | -1 | 5 | 2 | 0 | -21 |
| Employees | 310 | 350 | 350 | 345 | 325 | 295 | 335 | 335 | 295 | 260 | 220 |
| Vectura (SEK m.) | |||||||||||
| Sales | 28 | 130 | 34 | 35 | 35 | 26 | 124 | 38 | 32 | 34 | 20 |
| EBITDA | 15 | 73 | 15 | 23 | 22 | 13 | 76 | 28 | 21 | 22 | 5 |
| EBITDA (%) | 54 | 56 | 44 | 66 | 63 | 50 | 61 | 74 | 66 | 65 | 25 |
| Net debt (Grand Group/Vectura) | 1 294 | 1 278 | 1 278 | 1 122 | 1 098 | 1 015 | 943 | 943 | 986 | 951 | 876 |
| Financial Investments | |||||||||||
| EQT (SEK m.) | |||||||||||
| Reported value | 13 991 | 13 522 | 13 522 | 13 490 | 13 287 | 11 852 | 11 615 | 11 615 | 10 305 | 11 816 | 10 923 |
| Reported value change, % | 8 | 38 | 10 | 3 | 13 | 10 | 22 | 12 | 2 | 7 | 1 |
| Value change, constant currency, % | 8 | 30 | 6 | 2 | 10 | 9 | 20 | 10 | 4 | 2 | 4 |
| Draw-downs from Investor | 868 | 2 389 | 387 | 1 161 | 841 | 367 | 1 914 | 606 | 543 | 390 | 375 |
| Proceeds to Investor | 1 426 | 4 854 | 1 714 | 1 314 | 1 826 | 1 235 | 3 697 | 565 | 2 339 | 213 | 580 |
| Net proceeds to Investor | 558 | 2 465 | 1 327 | 153 | 985 | 868 | 1 783 | -41 | 1 796 | -177 | 205 |
| Investor Growth Capital (SEK m.) | |||||||||||
| Reported value | 15 119 | 12 081 | 12 081 | 11 697 | 11 328 | 11 357 | 10 793 | 10 793 | 11 102 | 10 772 | 10 701 |
| Reported value change, % | 25 | 20 | 4 | 6 | 1 | 9 | 13 | 3 | 6 | 3 | 1 |
| Value change, constant currency, % | 14 | 1 | -4 | -1 | -3 | 9 | 14 | 2 | 10 | 1 | 1 |
| Capital contribution from Investor | - | - | - | - | - | - | - | - | - | - | - |
| Distribution to Investor | 13 | 883 | 79 | 337 | 105 | 362 | 1 308 | 678 | 267 | 250 | 113 |
| Partner-owned investments | |||||||||||
| 3 Scandinavia2) | |||||||||||
| Sales | 2 663 | 10 387 | 2 994 | 2 677 | 2 392 | 2 324 | 9 459 | 2 687 | 2 219 | 2 316 | 2 237 |
| Sweden, SEK m. | 1 724 | 6 633 | 1 813 | 1 623 | 1 655 | 1 542 | 6 251 | 1 762 | 1 487 | 1 512 | 1 490 |
| Denmark, DKK m. | 746 | 3 063 | 940 | 858 | 606 | 659 | 2 756 | 777 | 633 | 694 | 652 |
| EBITDA | 696 | 2 662 | 691 | 675 | 678 | 618 | 2 344 | 720 | 629 | 512 | 483 |
| Sweden, SEK m. | 512 | 1 868 | 486 | 460 | 489 | 433 | 1 613 | 517 | 423 | 346 | 327 |
| Denmark, DKK m. | 146 | 649 | 163 | 175 | 155 | 156 | 628 | 169 | 180 | 142 | 137 |
| EBITDA, % | 26 | 26 | 23 | 25 | 28 | 27 | 25 | 27 | 28 | 22 | 22 |
| Sweden | 30 | 28 | 27 | 28 | 30 | 28 | 26 | 29 | 28 | 23 | 22 |
| Denmark | 20 | 21 | 17 | 20 | 26 | 24 | 23 | 22 | 28 | 20 | 21 |
| Net debt, SEK m. | 1 116 | 1 118 | 1 118 | 8 419 | 8 891 | 9 199 | 9 523 | 9 523 | 9 779 | 9 871 | 10 211 |
| Employees | 2 120 | 2 185 | 2 185 | 2 105 | 2 065 | 2 055 | 2 050 | 2 050 | 2 030 | 2 030 | 1 980 |
1) Consolidated as of May 14, 2013, figures for prior periods provided for comparison.
2) As of the fourth quarter 2014, 3 Scandinavia reports all financial information without the previously applied one-month delay. The key figures have been restated to enable comparability.
Net debt totaled SEK 24,086 m. on March 31, 2015 (24,832). Debt financing of the subsidiaries within Core Investments is arranged on an independent ring-fenced basis and hence not included in Investor's net debt. Within Financial Investments, Investor guarantees SEK 0.7 bn. of 3 Scandinavia's external debt, but this is not included in Investor's net debt.
| SEK m. | Consolidated balance sheet |
Deductions related to Core Investments subsidiaries and IGC |
Investor's net debt |
|---|---|---|---|
| Other financial investments | 4 048 | -2 | 4 0461) |
| Cash, bank and short-term investments |
16 338 | -8 982 | 7 3561) |
| Receivables included in | |||
| net debt | 2 552 | - | 2 552 |
| Loans | -51 498 | 13 600 | -37 898 |
| Provision for pensions | -781 | 639 | -142 |
| Total | -29 341 | 5 255 | -24 086 |
1) Included in cash and readily available placements.
Investor's cash and readily available placements amounted to SEK 11,402 m. as of March 31, 2015 (11,218). The shortterm investments are invested conservatively, taking into account the risk-adjusted return profile. Gross debt excluding pensions for Investor amounted to SEK 35,346 m. at the end of the first quarter 2015 (35,825).
The average maturity of Investor AB's debt portfolio was 11.1 years on March 31, 2015 (11.3), excluding the debt of Mölnlycke Health Care, Aleris, Permobil and Grand Group/Vectura.
| SEK m. | Group - Net Financial Items |
Deductions related to Core Investments subsidiaries and IGC |
Investor's Net Financial Items |
|---|---|---|---|
| Interest income | 19 | -7 | 12 |
| Interest expenses | -370 | 76 | -294 |
| Realized result from loans and swaps |
- | - | - |
| Unrealized result from revaluation of loans, swaps |
|||
| and short-term investments | 46 | 3 | 49 |
| Foreign exchange result | 84 | -7 | 77 |
| Other | -104 | 21 | -83 |
| Total | -325 | 86 | -239 |
The price of the A-share and B-share was SEK 337.70 and SEK 343.70 respectively on March 31, 2015, compared to SEK 281.30 and SEK 284.70 on December 31, 2014.
The total shareholder return amounted to 21 percent during the first quarter 2015 (6).
The total market capitalization of Investor, adjusted for repurchased shares, was SEK 259,942 m. as of March 31, 2015 (215,705).
| Class of share |
Number of shares |
Number of votes |
% of capital |
% of votes |
|---|---|---|---|---|
| A 1 vote | 311 690 844 | 311 690 844 | 40.6 | 87.2 |
| B 1/10 vote | 455 484 186 | 45 548 418 | 59.4 | 12.8 |
| Total | 767 175 030 | 357 239 262 | 100.0 | 100.0 |
On March 31, 2015, Investor owned a total of 5,429,779 of its own shares (5,796,960). The net decrease in holdings of own shares is attributable to repurchase of own shares and transfer of shares and options within Investor's long-term variable remuneration program.
The Board of Directors and the President propose a dividend to the shareholders of SEK 9.00 per share for fiscal year 2014 (8.00). The dividend level proposed is based on the stated dividend policy to declare dividends attributable to a high percentage of dividends received from listed core investments, as well as to make a distribution from other net assets corresponding to a yield in line with the equity market. Investor's goal is also to generate a steadily rising dividend.
Investor AB's Annual General Meeting will be held at 3:00 p.m. on Tuesday, May 12, 2015, at the City Conference Centre, Barnhusgatan 12-14, Stockholm. The registration commences at 1:30 p.m.
Notification of participation in the Annual General Meeting can be given until May 6, 2015. Notification can be given on Investor's website, (www.investorab.com), or by phoning +46 8 611 2910. Additional information about Investor's Annual General Meeting is available on Investor's website.
As it has during the past 15 years, Investor's Board of Directors has decided to propose to the 2015 Annual General Meeting that it should extend the authorization of the Board to decide on the repurchase of the company's shares. Under such a mandate, the Board would be given the opportunity until the next Annual General Meeting – provided it deems it appropriate – to decide on the repurchase of the company's shares. In accordance with current legislation, repurchases can total up to 10 percent of the total shares outstanding in Investor. Any repurchases may be effected over the stock exchange or through offerings to shareholders. It is also proposed that the Board's mandate include the possibility to transfer repurchased shares including transfers to participants in Investor's Long-term variable remuneration program. See also "Long-term variable remuneration program" below.
As in the previous nine years, the Board of Directors will propose a share-based, long-term variable remuneration program for Investor's employees at the 2015 Annual General Meeting.
The program will be substantially identical to the program for 2014. It is proposed that the long-term variable remuneration program be hedged as before through the repurchase of the company's shares, or through total return swaps. The Board's final proposal will be announced in the Notice of the 2015 Annual General Meeting.
On February 24, 2015, Aleris signed an agreement to acquire the healthcare provider, Teres Medical Group. The acquisition enables Aleris to strengthen its position as the leading private healthcare provider in Scandinavia. Teres has 17 surgical clinics and private hospitals in Norway, Denmark and Sweden. Through the acquisition, Aleris adds experience, competence and a broader range of high quality within different surgical services in Scandinavia. The transaction is subject to approval from competition authorities.
On March 25, 2015, Permobil announced the acquisition of The ROHO Group, Inc., the global leader in skin protection and positioning solutions for wheelchair users, based in Belleville, Illinois, U.S. The acquisition marks the next important step in Permobil´s strategy to become a leading healthcare company, providing innovative advanced rehabilitation solutions for people with disabilities. The transaction is subject to approval from competition authorities.
No significant changes of pledged assets and contingent liabilities occurred during the period.
This Interim Management Statement has in all material aspects been prepared in accordance with NASDAQ Stockholm's guidelines for preparing interim management statements. The accounting policies that have been applied for the consolidated income statement and consolidated balance sheet, are in agreement with the accounting policies used in the preparation of the company's most recent annual report. The financial statements and the segment information correspond to the disposition in the interim reports prepared in accordance with IAS 34. This in order to facilitate comparison in the presentation between quarters. This Interim Management Statement include among other President's comments and share price development, even though this is not required in the NASDAQ Stockholm's guidelines for preparing interim management statements. This information is however considered important to meet the needs of the users of the report.
The unprecedented macroeconomic stimulus through cheap money and low oil prices continued. In an environment with low, or even negative interest rates, yield-chasing investors have nowhere to turn but to the stock market. It is thus not surprising that the stock market continued to perform strongly during the quarter.
One important question in judging whether the current valuation levels – high by historical comparison – are sustainable is naturally to understand for how long the low interest environment will prevail. While not convinced myself, it cannot be ruled out that it will stay with us for a long time. The Western economies continue to be under deflationary pressure due to, for example, technology advances and an abundant availability of low-cost manufacturing. It is hard to see that either force will subside near term. The urbanization is not yet over in China, and in Africa, it hasn't really started.
We continued to increase our position in ABB, reaching 8.9 percent of the capital and votes.
Mölnlycke Health Care continued to grow with stable profitability. The restructuring of Aleris' Stockholm hospitals proceeded according to plan. In addition, Aleris signed an agreement to acquire Teres Medical Group, a major provider of a broad range of healthcare services. For all subsidiaries, bolt-on acquisitions are a core part of our strategy.
Permobil had a meagre quarter due to weak markets. In addition, the introduction of a new powered wheelchair series led to customers postponing purchases. We expect the product introduction to continue to impact sales and profitability during the second quarter as well, as production is ramped up. Permobil also announced the acquisition of ROHO Group to broaden its product offering.
This is my last quarterly report after almost ten years as your CEO. As of May 13, I will devote my time to our new division Patricia Industries. For the next 18-36 months, Patricia's top priority will be to step up the efforts to grow and develop the existing holdings and to realize the value of some of the financial holdings. You should expect limited new investments during this initial period, although we will for sure remain open for business. We plan to present the full structure of Patricia in our report for the second quarter.
The old advice to always recruit and work with people that are smarter than yourself has always been my True North. Therefore, I am confident that Johan Forssell and his team will take Investor to the next level.
At last, I want to acknowledge that I feel like I am the luckiest man on the face of the earth. I have had a great ten years, but more importantly, I have had my family by my side on the journey. I realize that they have made many sacrifices during the years, but they have always stood by me, in good times and bad. For this, I am very grateful.
With that, once again, thank you dear shareholders. It has been an honor to look after your company. Following the advice of Marilyn Monroe's movie character that "A wise girl… leaves before she is left" – over and out.
Stockholm, April 21, 2015
Börje Ekholm President and Chief Executive Officer
| May 12, 2015 | Annual General Meeting |
|---|---|
| Jul. 16, 2015 | Interim Report January-June 2015 |
| Oct. 23, 2015 | Interim Management Statement January September 2015 |
| Jan. 28, 2016 | Year-end Report |
Helena Saxon, Chief Financial Officer: +46 8 614 2000 [email protected]
Stefan Stern, Head of Corporate Relations and Communications: +46 8 614 2058 +46 70 636 7417 [email protected]
Magnus Dalhammar, Head of Investor Relations: +46 8 614 2130, +46 73 524 2130 [email protected]
Investor AB (publ) (CIN 556013-8298) SE-103 32 Stockholm, Sweden Visiting address: Arsenalsgatan 8C Phone: +46 8 614 2000 Fax: + 46 8 614 2150 www.investorab.com
Ticker codes:
INVEB SS in Bloomberg INVEb.ST in Reuters INVE B in NASDAQ
The information in this Interim Management Statement is such that Investor is required to disclose under Sweden's Securities Market Act.
The Interim Management Statement was released for publication at 08:15 CET on April 21, 2015.
This Interim Management Statement and additional information is available on www.investorab.com
This Interim Management Statement has not been subject to review by the company's auditors
| Dividends 3 671 3 385 Other operating income 16 52 Changes in value 30 197 8 893 Net sales 5 728 4 883 Cost of goods and services sold -3 650 -3 181 Sales and marketing cost -693 -749 Administrative, research and development and other operating cost -647 -542 Management cost -95 -90 Share of results of associates 122 157 Operating profit/loss 34 649 12 808 Net financial items -325 -481 Profit/loss before tax 34 324 12 327 Income taxes -311 -164 Profit/loss for the period 34 013 12 163 Attributable to: Owners of the Parent Company 34 013 12 142 Non-controlling interest 0 21 Profit/loss for the period 34 013 12 163 Basic earnings per share, SEK 44.66 15.96 Diluted earnings per share, SEK 44.55 15.92 |
SEK m. | 1/1-3/31 2015 | 1/1-3/31 2014 |
|---|---|---|---|
| SEK m. | 1/1-3/31 2015 | 1/1-3/31 2014 |
|---|---|---|
| Profit for the period | 34 013 | 12 163 |
| Other comprehensive income for the period, including tax | ||
| Items that will not be recycled to profit/loss for the period | ||
| Revaluation of property, plant and equipment | 13 | 64 |
| Remeasurements of defined benefit plans | 75 | - |
| Items that have been or may be recycled to profit/loss for the period |
||
| Cash flow hedges | -6 | -48 |
| Foreign currency translation adjustment | 739 | -9 |
| Share of other comprehensive income of associates | -53 | -13 |
| Total other comprehensive income for the period | 768 | -6 |
| Total comprehensive income for the period | 34 781 | 12 157 |
| Attributable to: | ||
| Owners of the Parent Company | 34 781 | 12 136 |
| Non-controlling interest | 0 | 21 |
| Total comprehensive income for the period | 34 781 | 12 157 |
| SEK m. | 3/31 2015 | 12/31 2014 | 3/31 2014 |
|---|---|---|---|
| ASSETS | |||
| Goodwill | 26 948 | 27 417 | 25 855 |
| Other intangible assets | 11 051 | 11 268 | 11 513 |
| Property, plant and equipment | 5 810 | 5 701 | 4 823 |
| Shares and participations | 278 480 | 246 823 | 210 247 |
| Other financial investments | 4 048 | 3 283 | 1 449 |
| Long-term receivables included in net debt | 2 477 | 2 053 | 276 |
| Other long-term receivables | 4 403 | 4 688 | 3 745 |
| Total non-current assets | 333 217 | 301 233 | 257 908 |
| Inventories | 1 995 | 1 785 | 1 439 |
| Shares and participations in trading operation | 86 | 68 | 789 |
| Short-term receivables included in net debt | 75 | - | 1 |
| Other current receivables | 6 978 | 4 131 | 6 270 |
| Cash, bank and short-term investments | 16 338 | 16 270 | 15 306 |
| Total current assets | 25 472 | 22 254 | 23 805 |
| TOTAL ASSETS | 358 689 | 323 487 | 281 713 |
| EQUITY AND LIABILITIES | |||
| Equity | 295 824 | 260 993 | 227 931 |
| Long-term interest bearing liabilities | 48 901 | 51 096 | 44 116 |
| Provisions for pensions and similar obligations | 781 | 853 | 650 |
| Other long-term provisions and liabilities | 5 152 | 4 938 | 4 140 |
| Total non-current liabilities | 54 834 | 56 887 | 48 906 |
| Current interest bearing liabilities | 2 597 | 240 | 287 |
| Other short-term provisions and liabilities | 5 434 | 5 367 | 4 589 |
| Total current liabilities | 8 031 | 5 607 | 4 876 |
| TOTAL EQUITY AND LIABILITIES | 358 689 | 323 487 | 281 713 |
| SEK m. | 1/1-3/31 2015 | 1/1-12/31 2014 | 1/1-3/31 2014 |
|---|---|---|---|
| Opening balance | 260 993 | 215 966 | 215 966 |
| Profit for the period | 34 013 | 50 688 | 12 163 |
| Other comprehensive income for the period | 768 | 1 969 | -6 |
| Total comprehensive income for the period | 34 781 | 52 657 | 12 157 |
| Dividends paid | - | -6 089 | - |
| Changes in non-controlling interest | 0 | -1 073 | -2 |
| Reclassification of non-controlling interest | - | -562 | -221 |
| Repurchase of own shares | - | - | - |
| Effect of long-term share-based remuneration | 50 | 94 | 31 |
| Closing balance | 295 824 | 260 993 | 227 931 |
| Attributable to: | |||
| Owners of the Parent Company | 295 790 | 260 963 | 227 584 |
| Non-controlling interest | 34 | 30 | 347 |
| Total equity | 295 824 | 260 993 | 227 931 |
| SEK m. | 1/1-3/31 2015 | 1/1-3/31 2014 |
|---|---|---|
| Operating activities | ||
| Core Investments | ||
| Dividends received | 1 190 | 778 |
| Cash receipts | 5 372 | 4 823 |
| Cash payments | -4 784 | -4 238 |
| Financial Investments and management cost | ||
| Dividends received | 99 | 470 |
| Net cash flow, trading operation | -19 | -435 |
| Cash payments | -129 | -277 |
| Cash flows from operating activities before net interest and income tax | 1 729 | 1 121 |
| Interest received/paid | -261 | -309 |
| Income tax paid | -74 | -77 |
| Cash flows from operating activities | 1 394 | 735 |
| Investing activities | ||
| Acquisitions | -2 352 | -864 |
| Divestments | 1 411 | 1 914 |
| Increase in long-term receivables | -17 | -1 |
| Decrease in long-term receivables | 252 | 22 |
| Acquisitions of subsidiaries, net effect on cash flow | -11 | -79 |
| Increase in other financial investments | -5 190 | -732 |
| Decrease in other financial investments | 4 434 | 1 044 |
| Net change, short-term investments | 873 | -3 005 |
| Acquisitions of property, plant and equipment | -206 | -242 |
| Proceeds from sale of property, plant and equipment | 1 | 2 |
| Proceeds from sale of other investments | - | -1 |
| Net cash used in investing activities | -805 | -1 942 |
| Financing activities | ||
| Borrowings | 118 | 1 813 |
| Repayment of borrowings | -74 | -11 |
| Net cash used in financing activities | 44 | -10 614 |
| Cash flows for the period | 633 | 595 |
| Cash and cash equivalents at the beginning of the year | 13 443 | 9 783 |
| Exchange difference in cash | 415 | 22 |
| Cash and cash equivalents at the end of the period | 14 491 | 10 400 |
| Core | Financial | Investor | ||
|---|---|---|---|---|
| SEK m. | investments | investments | Groupwide | Total |
| Dividends | 3 668 | 3 | - | 3 671 |
| Other operating income1) | 0 | 16 | - | 16 |
| Changes in value | 27 071 | 3 126 | - | 30 197 |
| Net sales | 5 713 | 15 | - | 5 728 |
| Cost of goods and services sold | -3 650 | 0 | - | -3 650 |
| Sales and marketing cost | -686 | -7 | - | -693 |
| Administrative, research and development and | ||||
| other operating cost | -599 | -47 | -1 | -647 |
| Management cost | -34 | -12 | -49 | -95 |
| Share of results of associates | -1 | 124 | -1 | 122 |
| Operating profit/loss | 31 482 | 3 218 | -51 | 34 649 |
| Net financial items | -87 | 1 | -239 | -325 |
| Income tax | -101 | -195 | -15 | -311 |
| Profit/loss for the period | 31 294 | 3 024 | -305 | 34 013 |
| Non-controlling interest | - | 0 | - | 0 |
| Net profit/loss for the period attributable to | ||||
| the Parent Company | 31 294 | 3 024 | -305 | 34 013 |
| Other effects on equity | -637 | 957 | 494 | 814 |
| Contribution to net asset value | 30 657 | 3 981 | 189 | 34 827 |
| Net asset value by business area 3/31 2015 | ||||
| Carrying amount | 278 300 | 39 074 | 2 502 | 319 876 |
| Investor's net debt | -24 086 | -24 086 | ||
| Total net asset value | 278 300 | 39 074 | -21 584 | 295 790 |
| Core | Financial | Investor | ||
|---|---|---|---|---|
| SEK m. | investments | investments | Groupwide | Total |
| Dividends | 2 915 | 470 | - | 3 385 |
| Other operating income1) | - | 52 | - | 52 |
| Changes in value | 7 265 | 1 628 | - | 8 893 |
| Net sales | 4 883 | - | - | 4 883 |
| Cost of goods and services sold | -3 181 | - | - | -3 181 |
| Sales and marketing cost | -746 | -3 | - | -749 |
| Administrative, research and development and other operating cost |
-517 | -25 | - | -542 |
| Management cost | -38 | -13 | -39 | -90 |
| Share of results of associates | 1 | 153 | 3 | 157 |
| Operating profit/loss | 10 582 | 2 262 | -36 | 12 808 |
| Net financial items | -82 | 0 | -399 | -481 |
| Income tax | 61 | -181 | -44 | -164 |
| Profit/loss for the period | 10 561 | 2 081 | -479 | 12 163 |
| Non-controlling interest | -21 | - | - | -21 |
| Net profit/loss for the period attributable to the Parent Company |
10 540 | 2 081 | -479 | 12 142 |
| Other effects on equity | 45 | -27 | 7 | 25 |
| Contribution to net asset value | 10 585 | 2 054 | -472 | 12 167 |
| Net asset value by business area 3/31 2014 | ||||
| Carrying amount | 212 658 | 33 276 | 3 573 | 249 507 |
| Investor's net debt | - | - | -21 923 | -21 923 |
| Total net asset value | 212 658 | 33 276 | -18 350 | 227 584 |
1) Includes interest on loans.
The numbers below are based on the same accounting and valuation policies as used in the preparation of the company's most recent annual report. For information regarding financial instruments in level 2 and level 3, see Note 29 in Investor's Annual Report 2014.
| Group 3/31 2015 | Fair value | Valuation technique | Input | Range |
|---|---|---|---|---|
| Shares and participations | 22 695 | Last round of financing | n.a. | n.a. |
| EBITDA multiples | 5.1 – 6.8 | |||
| Comparable companies | Sales multiples | 0.5 – 6.4 | ||
| Comparable transactions | Sales multiples | 1.4 – 7.1 | ||
| NAV | n.a. | n.a. | ||
| Long-term receivables included in net debt | 2 010 | Present value computation | Market interest rate | n.a. |
| Long-term interest bearing liabilities | 235 | Present value computation | Market interest rate | n.a. |
| Other long-term provisions and liabilities | 850 | Discounted Cash flow | n.a. |
All valuations in level 3 are based on assumptions and judgments that management consider to be reasonable based on the circumstances prevailing at the time. Changes in assumptions may result in adjustments to reported values and the actual outcome may differ from the estimates and judgments that were made.
The unlisted part of IGC's portfolio companies, corresponding to 52 percent of the portfolio value, is valued based on comparable companies, and the value is dependent on the level of the multiples. The multiple ranges provided in the note show the minimum and maximum value of the actual multiples applied in these valuations. A 10 percent change of the multiples would have an effect on the portfolio value of IGC of approximately SEK 600 m. For the derivatives, a parallel shift of the interest rate curve by one percentage point would affect the value by approximately SEK 1,200 m.
The table below indicates how fair value is measured for the financial instruments recognized at fair value in the Balance Sheet. The financial instruments are presented in three categories, depending on how the fair value is measured:
Level 1: According to quoted prices in active markets for identical instruments
Level 2: According to directly or indirectly observable inputs that are not included in level 1
Level 3: According to inputs that are unobservable in the market
| Group 3/31 2015 | Level 1 | Level 2 | Level 3 | Other1) | Total carrying amount |
|---|---|---|---|---|---|
| Financial assets | |||||
| Shares and participations | 250 329 | 2 274 | 22 695 | 3 182 | 278 480 |
| Other financial investments | 4 046 | 2 | 4 048 | ||
| Long-term receivables included in net debt | 467 | 2 010 | 2 477 | ||
| Shares and participations in trading operation | 86 | 86 | |||
| Short-term receivables included in net debt | 75 | 75 | |||
| Other current receivables | 68 | 6 910 | 6 978 | ||
| Cash, bank and short-term investments | 16 338 | 16 338 | |||
| Total | 270 799 | 2 884 | 24 705 | 10 094 | 308 482 |
| Financial liabilities | |||||
| Long-term interest bearing liabilities | 673 | 235 | 47 9932) | 48 9013) | |
| Other long-term provisions and liabilities | 850 | 4 302 | 5 152 | ||
| Short-term interest bearing liabilities | 152 | 2 445 | 2 597 | ||
| Other short-term provisions and liabilities | 29 | 200 | 5 205 | 5 434 | |
| Total | 29 | 1 025 | 1 085 | 59 945 | 62 084 |
1) To enable reconciliation with balance sheet items, financial instruments not valued at fair value as well as other assets and liabilities that are included within balance sheet items have been included within Other.
2) The Group's loans are valued at amortized cost.
3) Fair value on loans amounts to SEK 54,378 m.
| Long-term | Other long-term | |||
|---|---|---|---|---|
| Group 3/31 2015 | Shares and participations |
receivables included in net debt |
Long-term interest bearing liabilities |
provisions and liabilities |
| Opening balance | 21 869 | 1 382 | 231 | 840 |
| Total gain or losses in profit or loss statement | ||||
| in line Changes in value | 495 | 628 | 4 | |
| Reported in other comprehensive income | ||||
| in line Revaluation of property, plant and equipment | 17 | |||
| in line Foreign currency translation adjustment | 556 | 10 | ||
| Acquisitions | 1 125 | |||
| Divestments | -1 372 | |||
| Transfers to Level 3 | 5 | |||
| Carrying amount at end of period | 22 695 | 2 010 | 235 | 850 |
| Total gains/losses for the period included in profit/loss for instruments held at the end of the period (unrealized results) |
||||
| Changes in value | 495 | 628 | 4 |
No financial assets and liabilities have been set off in the Balance Sheet. The Groups derivatives are covered by ISDA agreements. For repurchase agreements GMRA agreements exist and for securities lending there are GMSLA agreements. According to the agreements the holder has the right to set off the derivatives and keep securities when the counterparty does not fulfill its commitments.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.